6.50MMarket Cap-1228P/E (TTM)
1.520High1.390Low85.29KVolume1.440Open1.400Pre Close124.25KTurnover1.98%Turnover RatioLossP/E (Static)4.48MShares4.50052wk High1.09P/B6.24MFloat Cap0.84152wk Low--Dividend TTM4.30MShs Float19.500Historical High--Div YieldTTM9.29%Amplitude0.841Historical Low1.456Avg Price1Lot Size
Silo Pharma Stock Forum
Update
$Silo Pharma (SILO.US)$ Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Silo Pharma Announces Partnership With Global Cro for Central Nervous System Homing Peptide
Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company, announced that it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. This collaboration is particularly focused on the advancement of Silo's lead candidate, SPC-15, an intranasal prophylactic treatment for post-...
this is one they call “gotcha!”
No comment yet